Is there a future for neuroprotective agents in cardiac surgery?
This article gives an overview of neuroprotective drugs that were recently tested in clinical trials in cardiac surgery. Also, recommendations are given for successful translational research and considerations for management during cardiac surgery.
van den Bergh
Walter M
WM
Department of Intensive Care, Academic Medical Center, Amsterdam, The Netherlands. w.m.vandenbergh@amc.nl
D002545:Brain Ischemia / Q000209:etiology / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000379:methods*; D002986:Clinical Trials as Topic; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D019990:Perioperative Care; D011183:Postoperative Complications / Q000517:prevention & control; D057170:Translational Research, Biomedical / Q000379:methods
D018696:Neuroprotective Agents